Relationship between thrombin activated fibrinolysis inhibitor in plasma and changes of coagulant and fibrinolytic function in type 2 diabetes / 国际检验医学杂志

ABSTRACT

Objective To evaluate the relationship of thrombin activated fibrinolysis inhibitor (TAFI) in plasma with changes of coagulant and fibrinolytic function in type 2 diabetes.Methods The plasma level of TAFI was measured by ELISA, fibrinogen was analyzed with Clauss assay and plasminogen was detected by chromogenic assay.Results The plasma levels of TAFI, Fib and the activity of PLG were significantly increased in type 2 diabetes with (P